RESEARCHGRADELABTESTED

AP / METABOLIC5MG

01PRODUCT DOSSIER

SEMAGLUTIDE

METABOLICRESEARCH

Long-acting GLP-1 receptor agonist analogue used in metabolic signalling research.

$89.00AUD

OUT OF STOCK

STRENGTH

QUANTITY

FORMATResearch Compound

DOCUMENTATIONPRODUCT COA

STORAGESTORE AT 2°C–8°C

DISPATCHAUSTRALIA-WIDE

02ABOUT THIS COMPOUND

WHAT IS SEMAGLUTIDE?

Semaglutide is a modified GLP-1 analogue studied for selective GLP-1 receptor activation and downstream effects on insulin secretion, glucagon signalling, gastric-emptying pathways and appetite-related neural circuits.

03RESEARCH APPLICATIONS

GLP-1 receptor signalling
Glucose-regulation pathways
Insulin and glucagon response models
Appetite and satiety signalling
Long-acting peptide pharmacology

04RESEARCH PROFILE

Well-characterised GLP-1 analogue
Selective single-receptor profile
Extensive metabolic research literature
Long-acting acylated peptide design
Multiple strengths available

RESEARCH USE ONLY

NOT FOR HUMAN CONSUMPTION / NOT FOR DIAGNOSTIC OR THERAPEUTIC USE

PEPTIDE CLASS

GLP-1 receptor agonist analogue

MOLECULAR WEIGHT

Approximately 4,114 Da

FORMAT

Lyophilised powder

APPEARANCE

White lyophilised powder

PURITY

≥ 98%

RESEARCH STATUS

Well-characterised research compound

AVAILABLE

5MG / 10MG / 20MG

RELATED COMPOUNDS

VIEW ALL PRODUCTS →